22nd International AIDS Conference (AIDS 2018) – second reports

24 August 2018. Related: Conference reports, Conference index, World AIDS 22 Amsterdam 2018.

23 – 27 July 2018, Amsterdam

The 22nd International AIDS Conference (AIDS 2018) was held this year from 23–27 July in Amsterdam.

Several thousand studies were presented as oral lectures or exhibited as posters over four days – so all reports touch on a minority of the research and activity – but much of the conference is also available online.

• Abstracts are online using a searchable database for the conference programme.
  http://programme.aids2018.org
• Clicking on a search result opens a separate window, either for the abstract or the session in which it was presented.
• Slides are available for most oral presentations and plenary lectures.
• Webcasts are available for many oral presentations (using the “video” link in the session window).
• Posters are available for many abstracts (using a PDF download link at the bottom of the abstract window).
• Oral abstracts are also available online and as a PDF supplement to JIAS.
  https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25148

Reports included in this issue of HTB.

• Namibia close to achieving 90-90-90 targets

• Dolutegravir monotherapy: still no longer recommended in either research or clinical practice

• Changing comorbidities in HIV positive people older than 60 at London clinic

• High acceptability of annual digital (finger) exam for early detection of anal cancer in gay men >35 years old

• High rates of anal HPV infection in gay men using PrEP in IPERGAY: the role of vaccination

• HCV incidence and reinfection in HIV negative gay men using PrEP in the Netherlands

• FDA-approved compounds that might selectively reverse HIV latency

• Lack of impact on viral reservoir with α4β7 monoclonal antibody vedolizumab: macaque results not matched in humans

• Viral load testing in Latin America and the Caribbean

• Access to viral load testing increased from 14% to 61% over two years in Côte d’Ivoire

• Resolving a diagnosis for people with persistently indeterminate HIV test results

• Dolutegravir dispersible tablets for infants and young children: early PK, safety and efficacy